StockData
Alpha Cognition Inc. logo

Alpha Cognition Inc. (ACOG) stock

ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3064% above fair value
$8.60+0.68 (+8.59%)

Close on Nov 18, 2026Market cap $187.29MP/E –Yield –

Alpha Cognition r&d expenses

Research and development expenses are spending on new products and technology.

Alpha Cognition's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.25M, up 49.4% year over year. For fiscal 2025 it was $1.87M, down 52.4% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.87M-52.4%
FY2024Dec 31, 2024$3.92M-19.7%
FY2023Dec 31, 2023$4.88M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.01M+394.6%
Q1 FY2026Mar 31, 2026$1.10M+173.8%
Q4 FY2025Dec 31, 2025$569.75K-45.2%
Q3 FY2025Sep 30, 2025$573.59K-42.4%
Q2 FY2025Jun 30, 2025$406.14K-58.0%
Q1 FY2025Mar 31, 2025$400.42K-56.3%
Q4 FY2024Dec 31, 2024$1.04M-6.3%
Q3 FY2024Sep 30, 2024$996.03K-30.3%
Q2 FY2024Jun 30, 2024$967.20K-22.4%
Q1 FY2024Mar 31, 2024$916.72K–
Q4 FY2023Dec 31, 2023$1.11M–
Q3 FY2023Sep 30, 2023$1.43M–
Q2 FY2023Jun 30, 2023$1.25M–

More Alpha Cognition figures

See a number that looks wrong?